Clinical Trials Directory

Trials / Completed

CompletedNCT05574790

Identification of Multimorbid Patients With a Higher Probability of Readmission and Mortality

Identification of Multimorbid Patients With a Higher Probability of Readmission and Mortality: Role of Patient-related Variables

Status
Completed
Phase
Study type
Observational
Enrollment
500 (actual)
Sponsor
Hospital Galdakao-Usansolo · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A prospective qualitative quantitative study was designed to create predictive models of readmission in multimorbid patients.

Detailed description

Social determinants have been shown to be related to the probability of readmission and death in multimorbid patients. These are increasingly older, which makes them more likely to be readmitted when their preferences are usually to be at home. Objective: To create and validate prediction models for readmission and mortality during home transitional period (1 month) and up to a year, in multimorbid patients, including variables related to the patient and their social environment. Design: Quali-quantitative. 4 hospitals from 3 regions (Andalucia, Catalonia and the Basque Country) will participate . Patients presenting at least 2 of the Ollero's categories will be included. Variables will be identified by means of nominal groups of professionals and focal groups with patients and caregivers. These variables will be included in the final models join to clinical variables, PROMS (health related quality of life, burden of the caregiver , social support). Logistic/ Cox regression models will be developed and validated internally to identify the risk of readmission and death which will be validated in an external cohort. Expected results: We hope to provide the health system with stratification tools for polypathological patients that help in identifying those patients with the greatest need for individualized interventions.

Conditions

Interventions

TypeNameDescription
OTHERannual follow upCollection of the following information during the year following discharge from the initial episode (initial cohort): readmissions, dates and causes of readmission, mortality

Timeline

Start date
2022-02-07
Primary completion
2022-06-30
Completion
2023-08-30
First posted
2022-10-12
Last updated
2023-09-22

Locations

4 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT05574790. Inclusion in this directory is not an endorsement.